Billionaires Holding CMRX

BILLIONAIRE ALLOCATION SHARES OWNED (M) % CO AVG. COST RETURN

FUNDAMENTALS

  • N/A
    PE

  • 0.0
    Yield

  • 36.5M
    Shares Outstanding

  • 1.277B
    Market Cap

News & Insights

ABOUT

CMRX

Chimerix, Inc. is a biopharmaceutical discovers and commercializes oral antiviral therapeutics. The Company develops novel antiviral therapeutics with the potential to transform patient care in multiple settings including transplant, oncology, acute care, and global health. Chimerix operates in t...

Apple And Berkshire Hathaway: When Two Worlds Collide

NEWS

Icahn: Best Bet On Commodities

READ MORE